The 2022-2027 Outlook for Antibody Drugs in Japan

This study covers the latent demand outlook for antibody drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Sports Medicine in Japan

This study covers the latent demand outlook for sports medicine across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the cit...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Natural Fatty Acids in Japan

This study covers the latent demand outlook for natural fatty acids across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Mental Disorder Drugs in Japan

This study covers the latent demand outlook for mental disorder drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share t...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Blood Products in Japan

This study covers the latent demand outlook for blood products across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Precious Metals in Japan

This study covers the latent demand outlook for precious metals across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the cit...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Over-the-Counter (OTC) Medicines and Dietary Supplements in Japan

This study covers the latent demand outlook for over-the-counter (OTC) medicines and dietary supplements across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each ci...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Milk Alternatives in Japan

This study covers the latent demand outlook for milk alternatives across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the c...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Flavors and Fragrances in Japan

This study covers the latent demand outlook for flavors and fragrances across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share ...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Feed Additives in Japan

This study covers the latent demand outlook for feed additives across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city...

11/4/2021 | Japan Outlook 2022

This study covers the latent demand outlook for antibody drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for antibody drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of antibody drugs as including all commonly understood products falling within this broad category, such as technologies in the research and development of antibody drugs for their therapeutic applications in human medicine, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, UCB, Takeda Pharmaceutical, Novartis, Merck, and Amgen. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for sports medicine across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for sports medicine. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of sports medicine as including all commonly understood products falling within this broad category, such as medicines for sports injuries medical devices for reconstruction products like orthopedic implants, fracture repairs, and prosthetics and braces, compression clothing, tapes, and wraps, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Arthrex, Covidien, Arthrocare, Breg, Cayenne Medical, and Biomet. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for natural fatty acids across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for natural fatty acids. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of natural fatty acids as including all commonly understood products falling within this broad category, such as fatty acids as an alternative to the petrochemical-based platform oleochemicals, biodiesel, and glycerin and derivatives of natural fatty acids such as soaps, dimers branched fatty acids, and fatty alcohols, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Alloco, Arizona Chemicals, Cremer Oleo, Vale Mining, Proctor & Gamble Chemicals, and Wilmar International. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for mental disorder drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for mental disorder drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of mental disorder drugs as including all commonly understood products falling within this broad category, such as psychiatric drugs used to treat mental disorders, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbvie, Cipla, Hospira, Purdue Pharma, Novartis, and Jazz Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for blood products across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for blood products. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of blood products as including all commonly understood products falling within this broad category, such as systems to provide and support collection, processing, and transfusion and technologies in collection, processing, screening, and blood therapeutics, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbot Laboratories, F. Hoffmann-La Roche, Pfizer, Bayer, Entegrion, and Baxter International. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for precious metals across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for precious metals. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of precious metals as including all commonly understood products falling within this broad category, such as technologies to obtain gold, silver, platinum, and recycled metals, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Vale, Vedanta Resources, Rio tinto, Goldcorp, Almaden Materials, and Codelco. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for over-the-counter (OTC) medicines and dietary supplements across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for over-the-counter (OTC) medicines and dietary supplements. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of over-the-counter (OTC) medicines and dietary supplements as including all commonly understood products falling within this broad category, such as tests and research studies in the reclassification of drugs, medicines, and dietary supplements from prescription to nonprescription status, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Sunson, DuPont, AB Enzymes, DSM, AUM Enzymes, and KDN Biotech. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for milk alternatives across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for milk alternatives. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of milk alternatives as including all commonly understood products falling within this broad category, such as milk substitutes that are plain-sweetened, plain-unsweetened, flavored sweetened, or flavored unsweetened and soy, almond, rice, oat, coconut, hemp, and hazelnut milk as a nondairy beverage, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Blue Diamond Growers, Kikkoman, Oatly, Pacific Natural Foods, The Whitewave Foods, and Organic Valley Family Of Farms. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for flavors and fragrances across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for flavors and fragrances. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of flavors and fragrances as including all commonly understood products falling within this broad category, such as flavor and fragrance blends essential oils and natural extracts aroma chemicals and flavors and fragrances used within the food, cosmetic and toiletry, cleaning product, beverage, and environmental fragrance good industries, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Mane, Robertet, Treatt, Givaudan, Bell Flavors & Fragrances, and Symrise. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for feed additives across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for feed additives. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of feed additives as including all commonly understood products falling within this broad category, such as antioxidant, amino acid, enzyme, vitamin, mineral, antibiotic, acidifier, and binder additives and feed additives used for cattle, poultry, swine, and aquatic animals, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Cargill, BASF, Evonik, Archer Daniels Midland, Invivo NSA, and Alltech. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT